Mark J Wall Selected Research

Mark J Wall Research Topics

Disease

5	AIDS-Related Complex (ARC) 11/2023 - 06/2014
4	Pathologic Processes 08/2013 - 01/2011
3	Hypoxia (Hypoxemia) 01/2017 - 09/2009
2	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 10/2022
2	Schizophrenia (Dementia Praecox) 01/2023 - 01/2022
2	Cognitive Dysfunction 10/2022 - 01/2022
2	Seizures (Absence Seizure) 01/2022 - 01/2018
2	Absence Epilepsy (Childhood Absence Epilepsy) 01/2021 - 11/2020
2	Pain (Aches) 12/2018 - 02/2008
2	Ischemia 01/2017 - 09/2011
2	Arthritis (Polyarthritis) 11/2011 - 03/2008
1	Tauopathies 01/2023
1	Bradycardia 01/2022
1	Hypotension (Low Blood Pressure) 01/2022
1	Respiratory Insufficiency (Respiratory Failure) 01/2022
1	Inflammation (Inflammations) 01/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Epilepsy (Aura) 02/2016
1	Amyloid Plaque 01/2016
1	Parkinson Disease (Parkinson's Disease) 01/2016
1	Chronic Pain 06/2012
1	Autolysis 10/2011
1	Starvation 09/2011
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2009
1	Neoplasm Metastasis (Metastasis) 11/2009
1	Adenocarcinoma of Lung 11/2009
1	Neoplasms (Cancer) 11/2009
1	Carcinoma (Carcinomatosis) 11/2009

Drug/Important Bio-Agent (IBA)

8	Adenosine (Adenocard)FDA LinkGeneric 01/2022 - 09/2009
6	Neurotransmitter Agents (Neurotransmitter)IBA 01/2022 - 01/2011
5	Proteins (Proteins, Gene)FDA Link 01/2018 - 10/2011
4	AMPA Receptors (AMPA Receptor)IBA 11/2023 - 06/2014
3	N- cyclobutyl- 6- ((3- fluorophenyl)ethynyl)nicotinamideIBA 01/2023 - 11/2020
3	purineIBA 01/2022 - 01/2011
2	Proteasome Endopeptidase Complex (Proteasome)IBA 11/2023 - 01/2018
2	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 11/2023 - 01/2021
2	VU0409551IBA 01/2023 - 01/2022
2	N-Type Calcium Channels (N-Type Calcium Channel)IBA 12/2018 - 06/2012
2	Vesicular Transport Adaptor ProteinsIBA 01/2018 - 05/2016
2	ClathrinIBA 01/2018 - 06/2014
2	4- cyano- N- (2- (1- cyclohexen- 1- yl)- 4- (1- ((dimethylamino)acetyl)- 4- piperidinyl)phenyl)- 1H- imidazole- 2- carboxamideIBA 11/2011 - 11/2009
2	Phosphotransferases (Kinase)IBA 11/2009 - 03/2008
1	3,4-dihydroxyphenylglycolIBA 11/2023
1	tau Proteins (tau Protein)IBA 01/2023
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2022
1	Analgesics (Analgesic Drugs)IBA 01/2022
1	Phencyclidine (Angel Dust)IBA 01/2022
1	Antipsychotic Agents (Antipsychotics)IBA 01/2022
1	Adenosine Triphosphate (ATP)IBA 01/2021
1	Dynamins (Dynamin)IBA 01/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	Ethanol (Ethyl Alcohol)IBA 01/2018
1	CalciumIBA 01/2017
1	IonsIBA 01/2017
1	PurinesIBA 02/2016
1	SynucleinsIBA 01/2016
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 06/2014
1	Glutamate Receptors (Glutamate Receptor)IBA 06/2014
1	UbiquitinIBA 06/2014
1	Ligases (Synthetase)IBA 06/2014
1	Conotoxins (Conotoxin)IBA 06/2012
1	ziconotide (Prialt)FDA Link 06/2012
1	Collagen Type II (Type II Collagen)IBA 11/2011
1	EnzymesIBA 10/2011
1	acetonitrileIBA 10/2011
1	Oxygen (Dioxygen)IBA 09/2011
1	Glutamic Acid (Glutamate)FDA Link 09/2011
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2009
1	Zoledronic Acid (Zometa)FDA Link 11/2009
1	Biomarkers (Surrogate Marker)IBA 11/2009
1	Macrophage Colony-Stimulating FactorIBA 11/2009
1	Macrophage Colony-Stimulating Factor Receptor (Receptor, Macrophage Colony Stimulating Factor)IBA 11/2009
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 11/2009
1	tyrosine receptor (receptor, tyrosine)IBA 11/2009
1	CollagenIBA 03/2008
1	Peptides (Polypeptides)IBA 02/2008
1	Cocaine (Cocaine HCl)IBA 02/2008
1	Amphetamine (Amfetamine)FDA LinkGeneric 02/2008

Therapy/Procedure

1	Therapeutics 10/2022